Skip to main content
SpringerLink
Log in
Book cover

Prävention von Thrombosen und Embolien in der Inneren Medizin pp 108–110Cite as

Modelle zur Risikoabschätzung

  • Chapter

This is a preview of subscription content, log in via an institution.

eBook
USD   9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

17 Literatur zu Teil IV (Kapitel 15–17)

  • Alikhan R, Cohen AT, Combe S et al. (2003) Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14: 341–346

    Article  PubMed  CAS  Google Scholar 

  • Alikhan R, Cohen AT, Combe S et al. (2004) Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 164: 963–968

    Article  PubMed  Google Scholar 

  • Anderson FA Jr, Wheeler HB, Goldberg RJ et al. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151: 933–938

    Google Scholar 

  • Belch JJ, Lowe GDO, Ward AG, Forbes CD, Prentice CRM (1981) Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 26: 115–117

    PubMed  CAS  Google Scholar 

  • Clarke-Pearson DL, Synan IS, Colemen RE, Hinshaw W, Creasman WT (1984) The natural history of postoperative venous thromboemboli in gynaecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol 148: 1051–1054

    PubMed  CAS  Google Scholar 

  • Cohen AT et al. (2003) J Thromb Haemost 1[Suppl 1]: P2046

    Google Scholar 

  • Emerson PA, Marks P (1977) Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking. BMJ 1: 18–20

    PubMed  CAS  Google Scholar 

  • Fraisse F, Holzapfel L, Coulaud J-M et al. (2000) Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med 161: 1109–1114

    PubMed  CAS  Google Scholar 

  • Geerts WH, Heit JA, Clagett GP et al. (2001) Prevention of venous thromboembolism. Chest 119: 132S–175S

    Article  PubMed  CAS  Google Scholar 

  • Handley AJ (1972) Low-dose heparin after myocardial infarction. Lancet 2: 623–624

    PubMed  CAS  Google Scholar 

  • Kierkegaard A, Norgren L, Olsson C-G, Castenfors J, Persson G, Persson S (1987) Incidence of deep vein thrombosis in bedridden non-surgical patients. Acta Med Scand 222: 409–414

    PubMed  CAS  Google Scholar 

  • Kleber F-X, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach CW, for THE-PRINCE Study Group (2003) A randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 145: 614–621

    Article  PubMed  CAS  Google Scholar 

  • Kniffin WD Jr, Baron JA, Barrett J et al. (1994) The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154: 861–866

    Article  PubMed  Google Scholar 

  • Laffen M, Tuddenham E (1998) Science, medicine, and the future: Assessing thrombotic risk. Br Med J 317: 520–523

    Google Scholar 

  • Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 17: 874–879

    Google Scholar 

  • Levine MN, Gent M, Hirsh J et al. (1988) The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 318: 404–407

    Article  PubMed  CAS  Google Scholar 

  • Lutz L, Haas S et al. (2002) Venöse Thromboembolie in der Inneren Medizin: Risikoeinschätzung und medikamentöse Prophylaxe. Med Welt 53: 231–234

    Google Scholar 

  • Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma. An evidence-based review. Cancer 89: 640–646

    Article  PubMed  CAS  Google Scholar 

  • Nicolaides AN, Breddin HK, Fareed J et al. (2001) Prevention of venous thromboembolism. International Consensus Statement Guidelines compiled in accordance with the scientific evidence. Int Angiol 20: 137

    Google Scholar 

  • Otten HMMB, Prins MH, Smorenburg SM, Hutten BA (2000) Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factor. Haemostasis 30[Suppl 2]: 72–76

    PubMed  Google Scholar 

  • Samama M-M (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. Arch Intern Med 160: 3415–3420

    Article  PubMed  CAS  Google Scholar 

  • Samama MM, Cohen AT, Darmon J-Y et al. (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 341: 793–800

    Article  PubMed  CAS  Google Scholar 

  • Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9: 286–294

    PubMed  CAS  Google Scholar 

  • Sutherland DE, Weitz IC, Liebman HA (2003) Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol 72: 43–52

    Article  PubMed  Google Scholar 

  • Warlow C, Beattie AG, Terry G, Ogston D, Kenmure ACF, Douglas AS (1973) A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet 2: 934–936

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Experimentelle Onkologie und Therapieforschung, Ismaninger Str. 22, 81675, München

    Sylvia Haas (Professor, Dr. med.) (Professor, Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Haas, S. (2005). Modelle zur Risikoabschätzung. In: Haas, S. (eds) Prävention von Thrombosen und Embolien in der Inneren Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27118-X_17

Download citation

  • DOI: https://doi.org/10.1007/3-540-27118-X_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22563-8

  • Online ISBN: 978-3-540-27118-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation